Global Information
회사소개 | 문의 | 비교리스트

세계의 시린지 충전기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Syringe Filling Machine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 989335
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,750 ₩ 6,306,000 PDF & Excel (Single User License)
US $ 5,250 ₩ 6,970,000 PDF & Excel (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,630,000 PDF & Excel (Site License)
US $ 8,750 ₩ 11,617,000 PDF & Excel (Corporate License)


세계의 시린지 충전기 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Syringe Filling Machine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

시린지 충전기 시장 규모는 2021-2026년의 예측 기간 중 9%의 CAGR로 성장할 것으로 예상되고 있습니다. 주사기 및 기타 RTU(ready-to-use) 컴포넌트 , 다양한 비경구 제형에 대한 채택의 증가는 시린지 충전기 시장의 성장을 지원할 것으로 예상됩니다.

  • 최근 제약 업계에서는 환자 안전, 노동 조건의 개선, 제조 비용의 절감에 대한 요구가 높아지고 있으므로 프리필드 시린지의 수요가 높아지고 있습니다. 시장에서는 몇개의 새로운 개발을 볼 수 있으며, With Hikma Pharmaceuticals는 2019년 9월에 미국에서 새로운 프리필드 시린지 기능을 발매한 최신 케이스입니다. With Hikma Pharmaceuticals는 헤파린 나트륨 주사액, USP, 5,000유닛/mL을 프리필드 시린지 형태로 공급합니다.
  • 또한 지속적 백신 접종을 필요로 하는 만성질환 치료의 수요 증가는 예측 기간 중 시린지 충전기의 채택을 지원할 것으로 예상됩니다.
  • EU/EEA의 복수 위험인자를 가진 주요 집단 그룹에서 B형 및 C형 간염의 유병률과 발생률에 관한 Eurosurveillance의 기사에 따르면 추정 7,110만 명이 각각 B형 간염 바이러스(HBV)와 C형 간염 바이러스(HCV)에 만성적으로 감염하고 있습니다. 이러한 경우 백신은 사전에 프리필드 시린지 형태로 입수할 수 있으므로 소비량의 증가는 시장의 성장을 지원할 것으로 예상됩니다.
  • 2019년 2월, BD는 BD HylokTM을 발매했습니다. 이것은 히알루론산 더말 필러 등의 점성 용액을 투여하기 위한 새로운 유리 프리필러블 시린지입니다. 1ml 길이의 포맷이 있으며, 향후 추가 사이즈가 도입되며 제품 또는 제약회사의 개발, 기술 등록 작업을 지원하기 위한 광범위한 데이터 패키지가 부속되어 있습니다.

세계의 시린지 충전기 시장을 조사했으며, 시장의 개요, 시장 성장요인 및 저해요인 분석, 시장 기회, 유형별·지역별 시장 규모의 추이와 예측, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

재3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 촉진요인과 제약의 서론
  • 시장 촉진요인
    • 기존 충전 방법을 쇄신할 필요성의 증가
    • 프리필드 시린지의 수요 증가
  • 시장 억제요인
    • 높은 설치 비용
  • 업계의 밸류체인 분석
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 유형별
    • 자동화
    • 반자동
    • 수동
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 남미
    • 중동과 아프리카

제6장 경쟁 구도

  • 기업 개요
    • Maquinaria Industrial Dara, Sl
    • Vanrx Pharmasystems Inc.
    • Nordson Corporation
    • Musashi Engineering, Inc.
    • IMA Industria Macchine Automatiche SPA
    • Romaco Group
    • Added Pharma BV
    • Automated Systems of Tacoma(AST)
    • Shenzhen Penglai Industrial Corporation Limited.
    • OPTIMA packaging group GmbH
    • Prosys Innovative Packaging Equipment

제7장 투자 분석

제8장 시장 기회 및 향후 전망

KSA 21.03.08

The syringe filling machine market is expected to register a CAGR of 9% during the forecast period (2021 - 2026). The increasing adoption of the syringes and other ready-to-use (RTU) components for a variety of parenteral dosage forms is expected to boost the growth of the syringe filling machine market.

Key Highlights

  • In recent years there has been a growing demand for prefilled syringes as there has been an increased need for patient safety, improved working conditions, and reduced cost of production in the pharmaceutical industry. The market has seen several new developments and With Hikma Pharmaceuticals being the latest to launch a new prefilled syringe capability in the United States in September 2019. The company would be supplying heparin sodium injection, USP, 5000 units/mL in prefilled syringe form.
  • Also, the growing demand to treat chronic diseases that require continuous vaccination is expected to boost the adoption of the syringe filling machines over the forecast period.
  • According to Eurosurveillance's article on Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA, an estimated 71.1 million people are chronically infected with the hepatitis B virus (HBV) and hepatitis C virus (HCV), respectively. As the vaccines for such cases are available in pre-filled syringes form, its increased consumption is expected to boost the market growth.
  • In February 2019 - BD launched BD HylokTM, its new glass pre-fillable syringe for the administration of viscous solutions such as hyaluronic acid dermal fillers available in 1ml long format, with additional sizes to be introduced in the future, and comes with an extensive data package to support product or drug manufacturers developmental, technical and registration efforts..

Key Market Trends

Increased Shelf Life and Reduction Of Wastage

  • It is estimated that the medication stored inside of a prefilled syringe cartridge will remain sterile for approximately two to three years when compared to a standard syringe which can be sterile for only 12 hours when filled. Also, the prefilled syringes have lesser overfill when compared to manual filling. It is estimated that for a 0.5 ml vial, the USP recommends 20-25% overfill. In contrast, for 0.5 ml, the required overfills are less than 2%. As a result, potentially 18-23% more doses can be produced.
  • Also, With the increasing technological disruptions taking place across industries, owing to the wide-adoption of Industry 4.0 and automation amongst others, the pharmaceutical industry is adopting new and effective methods of drug creation. Pharmaceutical syringe filling equipment allows companies to streamline the syringe packing process as these are capable of filling up to hundreds of syringes per minute.
  • The pharmaceutical syringe filling equipment maintains longer sterility and provides precise, automated control over barriers, tips, and additional accessories required for syringes. Moreover, the manufacturers can bring the the overal cost down with the help of high output pharmaceutical syringe filling machines.
  • In March 2019, the pharmaceutical packaging company Schott Kaisha expanded its capacity to manufacture vials, pre-filled syringes, and sterile solutions. The company's expansion plans include new sites in Gujarat and North India, along with the expansion and up-gradation of existing plants in Daman and Jambusar in Gujarat. These developments are expected to augment the market growth in the emerging economies as the pharmaceutical companies start adopting these machines for their drug creation.
  • The market is witnessing a rising need for infused product manufacturers for sufficient filling machinery for CBD and THC products. The CBD oil cartridges require filling equipment that can provide detailed parts, and simple changeover, and cleanup, quick turnaround, among other factors, due to which pharmaceutical companies have been more inclined towards syringe filling machine for CBD applications.
  • In February 2019, Optima Pharma introduced its MultiUse filler machine designed to process different types of containers in a flexible and fully automated way. Optima's MultiUse Filler fills vials, syringes, and cartridges with one machine and allows for small batch sizes and different container types. These initiatives by various pharmaceutical companies will further stimulate market growth.

North America is Expected to Hold Significant Share

  • The CDC, FDA, and NASEN are the main regulatory bodies in the North American region. These regulatory bodies have been increasingly promoting the safety of the patients that are administered with vaccines. The prefilled syringes are going to play an important role in the administration of the vaccine in the US as there are rising concerns about the overdose of vaccines administered to children.
  • Furthermore, this region has seen significant developments in the syringe filling machines, most recently NC-based Mission Health in Asheville, installed two RIV automated IV compounding systems from ARxIUM that sterile-fill liquids and lyophilized products into IV syringes, and bags for administration to Mission Health patients.
  • Also, The increasing number of chronic diseases in the region that require frequent vaccine usage is one of the prominent factors contributing to the growth of the market over the forecast period. According to the hepatitis B foundation, Up to 80,000 Americans will become newly infected with Hepatitis B each year, and more than 2 million Americans are chronically infected. More and more manufacturers in this region are getting approval for prefilled syringes for Hepatitis B vaccines. Dynavax was one of the major pharma company to receive FDA approval for their pre-filled syringe vaccine HEPLISAV-B in March 2018.
  • The technological advancements in the region in terms of robotics is one of the prominent factors that would drive the growth of the syringe filling machine in the region. For instance, FP Developments that provide syringe filling and handling, vial filling and handling, mark and verify, track-and-trace, unique device identification (UDI) uses a Universal Robots UR-3 robotic arm to perform aseptic syringe filling and capping.

Competitive Landscape

The market is highly fragmented with the presence of some key players such as Nordson Corporation, Romaco Group, and many smaller players. Innovation and cost have been a crucial factor for the companies operating in this market.

  • April 2019 - Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) and Automated Systems of Tacoma, LLC (AST), a provider of flexible aseptic filling systems, announce their partnership on the new GENiSYS R filling machine for syringes, cartridges, and vials. GENiSYS R's adaptive approach uses flexible robotic automation to process ready-to-fill vials, syringes, and cartridges on the same machine. Both peristaltic and rotary piston dispensing systems are available to accurately fill each container directly on an electronic balance to provide up to 100% in-process fill weight inspection.
  • December 2019 - Steriline, launched its robotic nest filling machine, the new machine is a compact filling machine specifically designed to be used in laboratories.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 The Rising Need to Replace the Conventional Filling Method
    • 4.3.2 The Rising Demand For the Prefilled Syringes
  • 4.4 Market Restraints
    • 4.4.1 High installation Cost
  • 4.5 Industry Value Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Force Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Automated
    • 5.1.2 Semi-Automated
    • 5.1.3 Manual
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia Pacific
    • 5.2.4 South America
    • 5.2.5 Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Maquinaria Industrial Dara, Sl
    • 6.1.2 Vanrx Pharmasystems Inc.
    • 6.1.3 Nordson Corporation
    • 6.1.4 Musashi Engineering, Inc.
    • 6.1.5 I.M.A. Industria Macchine Automatiche S.P.A.
    • 6.1.6 Romaco Group
    • 6.1.7 Added Pharma B.V.
    • 6.1.8 Automated Systems of Tacoma (AST)
    • 6.1.9 Shenzhen Penglai Industrial Corporation Limited.
    • 6.1.10 OPTIMA packaging group GmbH
    • 6.1.11 Prosys Innovative Packaging Equipment

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q